COMMUNIQUÉS West-GlobeNewswire

Grandevo® CG and Regalia® CG Approved by the California Department of Pesticide Regulation

25/07/2018 - 14:31

Innovative Tools for a New Era: Grandevo® CG and Regalia® CG Are Effective Tools for Controlling Economically Damaging Mites, Insect Pests and Plant Diseases and Boosting Yields and Quality for Cannabis DAVIS, Calif., [...]

OpGen Announces Date of Second Quarter 2018 Financial Results Conference Call

25/07/2018 - 14:30

GAITHERSBERG, Md., July 25, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that the Company will report financial results for the three and six months ended June 30, 2018 after close of the U.S. [...]

Imagin Medical Announces Stock Options Granted

25/07/2018 - 14:30

VANCOUVER, B.C. and BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) announced today that, pursuant to the Company’s Stock Option [...]

OrthoPediatrics Corp. to Report Second Quarter 2018 Financial Results on August 8, 2018

25/07/2018 - 14:30

Conference Call to Discuss Results on August 9, 2018 at 8:00 a.m. ET WARSAW, Ind., July 25, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on [...]

Albireo Appoints Patrick Horn MD, PhD as Chief Medical Officer

25/07/2018 - 14:30

--- Pediatrician with extensive orphan drug development expertise --- --- Experience with multiple Phase 3 programs and FDA submissions --- BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a [...]

Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics

25/07/2018 - 14:30

CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced that it [...]

Nabriva Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

25/07/2018 - 14:30

DUBLIN, Ireland and KING OF PRUSSIA, Pa. and SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of [...]

Bespoke Extracts Supports Make a Difference Foundation’s Provision of Blanket Warming System for Patients in Treatment at Florida Cancer Specialists & Research Institute in West Palm Beach

25/07/2018 - 14:30

SUNNY ISLES, Fla., July 25, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, is pleased to announce its support of Make A [...]

Syntactx Announces Expansion of Regulatory Affairs Leadership Team

25/07/2018 - 14:30

Company Names Three Industry Veterans to Lead Regulatory Affairs Team: Marlene Barton, Vice President, Department Head; Chie Iwaishi, Senior Director; and Darlene Garner, Manager Appointments Reflect Company’s Enhanced [...]

Endocyte Announces Second Quarter 2018 Financial Results and Operational Update Call

25/07/2018 - 14:01

WEST LAFAYETTE, Ind., July 25, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company will [...]

Sientra to Present at the Canaccord 38th Annual Growth Stock Conference

25/07/2018 - 14:00

SANTA BARBARA, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of the management team are scheduled to present at the Canaccord 38 th [...]

Minerva Neurosciences Names Devin Smith Senior Vice President, General Counsel

25/07/2018 - 14:00

WALTHAM, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

INSYS Therapeutics to Report Second Quarter 2018 Results on Aug. 8

25/07/2018 - 14:00

PHOENIX, July 25, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced that [...]

Immune Design to Report Second Quarter 2018 Financial Results and Provide Corporate Update

25/07/2018 - 14:00

SEATTLE and SOUTH SAN FRANCISCO, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report [...]

Apixio Launches HCC Auditor, the First AI-Powered Risk Adjustment Auditing Solution

25/07/2018 - 14:00

50 percent of health plan coders claim that their organization reviews less than 10 percent of charts pulled for risk adjustment coding – putting organizations at financial and compliance risk SAN MATEO, Calif., July 25 [...]

HempAmericana Provides Progress Update on CBD Oil Operations

25/07/2018 - 14:00

NEW YORK, July 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is proud to update shareholders and the wider investment community on the Company’s strong [...]

RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®

25/07/2018 - 14:00

Mytesi ® is an FDA-approved anti-diarrheal prescription drug indicated for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on anti-retroviral therapy (ART) Mytesi ® is the fourth product being [...]

Trogarzo(TM) Included in Most Recent Treatment Guidelines Issued by International Antiviral Society

25/07/2018 - 13:50

MONTREAL, July 25, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that Trogarzo™ (ibalizumab-uiyk) injection is now included in the most recent version of the [...]

L’International Antiviral Society ajoute Trogarzo(MC) à ses directives de traitement

25/07/2018 - 13:50

MONTRÉAL, 25 juill. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) est heureuse d’annoncer que Trogarzo MC (ibalizumab-uiyk) injection a été ajouté à la plus récente version des directives [...]